Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

NASDAQ:CROX - Nasdaq - US2270461096 - Common Stock - Currency: USD

107.34  +0.6 (+0.56%)

After market: 107.75 +0.41 (+0.38%)

Fundamental Rating

7

Taking everything into account, CROX scores 7 out of 10 in our fundamental rating. CROX was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX gets an excellent profitability rating and is at the same time showing great financial health properties. CROX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, CROX could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
In the past year CROX had a positive cash flow from operations.
CROX had positive earnings in each of the past 5 years.
CROX had a positive operating cash flow in each of the past 5 years.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

With an excellent Return On Assets value of 18.90%, CROX belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
Looking at the Return On Equity, with a value of 48.63%, CROX belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
The Return On Invested Capital of CROX (21.12%) is better than 91.67% of its industry peers.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 11.45%.
Industry RankSector Rank
ROA 18.9%
ROE 48.63%
ROIC 21.12%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

CROX has a Profit Margin of 23.35%. This is amongst the best in the industry. CROX outperforms 100.00% of its industry peers.
CROX's Profit Margin has improved in the last couple of years.
The Operating Margin of CROX (24.84%) is better than 97.92% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
Looking at the Gross Margin, with a value of 59.25%, CROX is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.84%
PM (TTM) 23.35%
GM 59.25%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CROX has been reduced compared to 1 year ago.
Compared to 5 years ago, CROX has less shares outstanding
CROX has a better debt/assets ratio than last year.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CROX has an Altman-Z score of 3.75. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.75, CROX is doing good in the industry, outperforming 68.75% of the companies in the same industry.
The Debt to FCF ratio of CROX is 1.68, which is an excellent value as it means it would take CROX, only 1.68 years of fcf income to pay off all of its debts.
CROX's Debt to FCF ratio of 1.68 is fine compared to the rest of the industry. CROX outperforms 79.17% of its industry peers.
CROX has a Debt/Equity ratio of 0.75. This is a neutral value indicating CROX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.75, CROX is doing worse than 66.67% of the companies in the same industry.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 1.68
Altman-Z 3.75
ROIC/WACC2.41
WACC8.75%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.52 indicates that CROX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.52, CROX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
CROX has a Quick Ratio of 1.52. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
CROX has a worse Quick ratio (0.97) than 62.50% of its industry peers.
The current and quick ratio evaluation for CROX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.97
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CROX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.55%.
The Earnings Per Share has been growing by 51.64% on average over the past years. This is a very strong growth
CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 2.09%.
The Revenue has been growing by 27.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)5.55%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-0.66%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-0.14%

3.2 Future

The Earnings Per Share is expected to grow by 2.84% on average over the next years.
Based on estimates for the next years, CROX will show a small growth in Revenue. The Revenue will grow by 2.29% on average per year.
EPS Next Y-1.91%
EPS Next 2Y0.92%
EPS Next 3Y-1.1%
EPS Next 5Y2.84%
Revenue Next Year1.71%
Revenue Next 2Y2.33%
Revenue Next 3Y1.73%
Revenue Next 5Y2.29%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.18 indicates a reasonable valuation of CROX.
87.50% of the companies in the same industry are more expensive than CROX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.45, CROX is valued rather cheaply.
The Price/Forward Earnings ratio is 8.02, which indicates a very decent valuation of CROX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 87.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, CROX is valued rather cheaply.
Industry RankSector Rank
PE 8.18
Fwd PE 8.02
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued a bit cheaper than the industry average as 77.08% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CROX is valued cheaper than 85.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.81
EV/EBITDA 6.69
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CROX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y0.92%
EPS Next 3Y-1.1%

0

5. Dividend

5.1 Amount

CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (7/3/2025, 7:14:07 PM)

After market: 107.75 +0.41 (+0.38%)

107.34

+0.6 (+0.56%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-30 2025-07-30/amc
Inst Owners101.51%
Inst Owner Change2.15%
Ins Owners2.49%
Ins Owner Change5.65%
Market Cap6.02B
Analysts81.82
Price Target129.76 (20.89%)
Short Float %11.87%
Short Ratio4.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.88%
Min EPS beat(2)9.31%
Max EPS beat(2)18.44%
EPS beat(4)4
Avg EPS beat(4)12.98%
Min EPS beat(4)9.31%
Max EPS beat(4)18.44%
EPS beat(8)8
Avg EPS beat(8)14.09%
EPS beat(12)12
Avg EPS beat(12)14.76%
EPS beat(16)16
Avg EPS beat(16)17.35%
Revenue beat(2)2
Avg Revenue beat(2)1.05%
Min Revenue beat(2)0.88%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.11%
Max Revenue beat(4)1.22%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)7
Avg Revenue beat(12)0.52%
Revenue beat(16)10
Avg Revenue beat(16)1.27%
PT rev (1m)4.67%
PT rev (3m)-1.57%
EPS NQ rev (1m)-0.32%
EPS NQ rev (3m)1.43%
EPS NY rev (1m)-1.58%
EPS NY rev (3m)-2.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-0.91%
Valuation
Industry RankSector Rank
PE 8.18
Fwd PE 8.02
P/S 1.47
P/FCF 6.81
P/OCF 6.32
P/B 3.06
P/tB N/A
EV/EBITDA 6.69
EPS(TTM)13.13
EY12.23%
EPS(NY)13.39
Fwd EY12.48%
FCF(TTM)15.76
FCFY14.69%
OCF(TTM)16.99
OCFY15.83%
SpS73.14
BVpS35.13
TBVpS-9.18
PEG (NY)N/A
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 18.9%
ROE 48.63%
ROCE 23.35%
ROIC 21.12%
ROICexc 21.96%
ROICexgc 53.87%
OM 24.84%
PM (TTM) 23.35%
GM 59.25%
FCFM 21.55%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 1.68
Debt/EBITDA 1.36
Cap/Depr 95.51%
Cap/Sales 1.68%
Interest Coverage 11.16
Cash Conversion 87.36%
Profit Quality 92.29%
Current Ratio 1.52
Quick Ratio 0.97
Altman-Z 3.75
F-Score6
WACC8.75%
ROIC/WACC2.41
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.55%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-0.66%
EPS Next Y-1.91%
EPS Next 2Y0.92%
EPS Next 3Y-1.1%
EPS Next 5Y2.84%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-0.14%
Revenue Next Year1.71%
Revenue Next 2Y2.33%
Revenue Next 3Y1.73%
Revenue Next 5Y2.29%
EBIT growth 1Y-4.07%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-0.47%
EBIT Next 3Y-3.04%
EBIT Next 5Y3.43%
FCF growth 1Y53.79%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y39.75%
OCF growth 3Y20.5%
OCF growth 5Y61.62%